JULIA SPEROS: Open Payments
NPI 1831681956 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 23 payments from 10 companies in 2025. Trend: 2023 $260 · 2024 $739 · 2025 $531
Food & beverage: $431Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $108 |
| Janssen Biotech, Inc. | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| GENZYME CORPORATION | 3 | $72 |
| PFIZER INC. | 3 | $52 |
| UCB, Inc. | 2 | $38 |
| Arcutis Biotherapeutics, Inc. | 2 | $32 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Organon LLC | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, Bimzelx, LITFULO, Zoryve, NEMLUVIO, CIBINQO.
Industry payments across OR — which companies pay providers there.
